Drugs

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

4 monthes ago   |   By Xconomy

The treatment landscape for lung cancer has shifted significantly over the past few years , and more changes could be on the way. At the World Conference on Lung Cancer in Barcelona this weekend a number of drug makers trotted out some of their latest advances in immunotherapy, targeted pills, drug combinations, and more. Xconomy rounded up some of the most noteworthy headlines and put them in context below. Spotlight on KRAS Over the past year, a drug called AMG 510, from Amgen has caused quite a stir, and for good reason. It's the first drug to inhibit...
Read more ...

 

Lilly's RET drug, nabbed in Loxo buyout, hits 68% ORR in lung cancer

Lilly's RET drug, nabbed in Loxo buyout, hits 68% ORR in lung cancer

4 monthes ago   |   By Fierce Biotech

BARCELONA-Now within the ownership of Eli Lilly, Loxo Oncology has presented new data at the World Conference on Lung Cancer for its RET inhibitor LOXO-292 as it plots an NDA in the coming months.
Read more ...

 


Search by Tags

   Drugs      Drug      Cancer      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      American Society of Clinical Oncology      AMG-510      Amgen      Andrew Berens      AstraZeneca      Atezolizumab      Blueprint Medicines      Cancer immunotherapy      Chemotherapy      Clinical trials      Colorectal Cancer      Data      Durvalumab      Eli Lilly      Imfinzi      Immunotherapy      Kennen MacKay      Keytruda      KRAS      Life Sciences      Loxo Oncology      Lung Cancer      Medullary thyroid cancer      Merck      Mirati Therapeutics      Non-Small Cell Lung Cancer      Pembrolizumab      RET fusion      Roche      Small cell lung cancer      SVB Leerink      World Conference on Lung Cancer  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Eric Seaborg Eric Seaborg, a writer and author, outdoorsman and environmentalist, has a love for hiking that he shared with his father, the late chemist and Nobel laureate... Read more ...

Project to Rapidly Sequence Maize Pangenome Delivers Publicly Available Resource

Project to Rapidly Sequence Maize Pangenome Delivers Publicly Available Resource

Matt Hufford, associate professor at Iowa State University, helped produce a 26-line maize pangenome assembly collection Maize researchers have been rejoicing over a New Year's... Read more ...

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme won accelerated FDA approval Thursday for a drug developed to treat the rare cancer epithelioid sarcoma. The regulatory decision for the Epizyme drug, tazemetostat... Read more ...

The Wuhan Coronavirus Inspires a Look Back at the Discovery of Viruses

The Wuhan Coronavirus Inspires a Look Back at the Discovery of Viruses

I'm astonished at the speed with which geneticists and epidemiologists are zeroing in on the Wuhan coronavirus. Nomenclature is still up in the air. The first name, “2019-nCoV”... Read more ...

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

MedImmune, AstraZeneca's biologics division, is no more. The pharmaceutical giant announced last year that the name would be retired as part of a research and development... Read more ...

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

Safety concerns stymied Sarepta Therapeutics' attempt to win FDA approval last August for golodirsen , its second Duchenne muscular dystrophy drug. But an appeal of the... Read more ...

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

The first treatment for a rare disease that causes eye bulging and double vision received an FDA nod on Tuesday, weeks ahead of the agency's March 8 deadline to review the... Read more ...

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

CRISPR gene editing offers the potential to selectively edit the genetic mutations causing inherited diseases, but Emendo Biotherapeutics CEO David Baram contends it's not... Read more ...

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOs of Women's Health Companies Fight to Open Investment Floodgates

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company recently submitted Amphora, a... Read more ...

Bachem: EHS Coordinator

Bachem: Your Responsibilities The Environmental, Health and Safety Coordinator will be responsible for providing full time environmental health and sa Vista, CA, US ... Read more ...